Trials / Conditions / Congenital Fibrinogen Deficiency
Congenital Fibrinogen Deficiency
5 registered clinical trials studyying Congenital Fibrinogen Deficiency.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency NCT03793426 | Octapharma | — |
| Completed | Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen NCT02408484 | Octapharma | Phase 3 |
| Completed | An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects Wi NCT02427217 | CSL Behring | — |
| Completed | Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding Duri NCT02267226 | Octapharma | Phase 3 |
| Completed | Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap NCT01575756 | Octapharma | Phase 2 |